Director's Dealing • Jun 30, 2020
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 5181R
Hemogenyx Pharmaceuticals PLC
30 June 2020
Director/PDMR Shareholding
Hemogenyx Pharmaceuticals plc (LSE: HEMO) announces that it has been notified that Andrew Wright, the Company's Financial Controller and Company Secretary (PDMR), and his wife, Olena Wright, have purchased a total of 434,704 ordinary shares of £0.01 each in the Company ("Ordinary Shares") at an average price of 5.76p per share. Following this transaction, Mr Wright has a total beneficial interest in 1,532,109 Ordinary Shares, representing approximately 0.35 per cent of the Company's issued share capital.
Market Abuse Regulation (MAR) Disclosure
Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Andrew Wright
b)
Position / status
PDMR: Financial Controller and Company Secretary
c)
Initial notification / amendment
Initial notification
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary shares of Hemogenyx Pharmaceuticals plc
Identification code GB00BYX3WZ24
b)
Nature of the transaction
Standalone acquisition of shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £0.056799 | 90,554 |
d)
Aggregated information
- Aggregated volume
- Price
| Price(s) | Volume(s) |
| £5,143.38 | 90,554 |
e)
Date of the transaction
2020-06-29
f)
Place of the transaction
London Stock Exchange
XLON
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Olena Wright
b)
Position / status
PCA: Spouse of Andrew Wright (PDMR: Financial Controller and Company Secretary)
c)
Initial notification / amendment
Initial notification
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary shares of Hemogenyx Pharmaceuticals plc
Identification code GB00BYX3WZ24
b)
Nature of the transaction
Standalone acquisition of shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £0.057799 | 344,150 |
d)
Aggregated information
- Aggregated volume
- Price
| Price(s) | Volume(s) |
| £19,891.53 | 344,150 |
e)
Date of the transaction
2020-06-29
f)
Place of the transaction
London Stock Exchange
XLON
Enquiries:
| Hemogenyx Pharmaceuticals plc | hemogenyx.com |
| Dr Vladislav Sandler, Chief Executive Officer & Co-Founder | [email protected] |
| Peter Redmond, Director | |
| SP Angel Corporate Finance LLP | Tel: +44 (0)20 3470 0470 |
| Matthew Johnson, Vadim Alexandre, Soltan Tagiev | |
| Peterhouse Capital Limited | Tel: +44 (0)20 7469 0930 |
| Lucy Williams, Duncan Vasey, Charles Goodfellow | |
| US Media enquiries | |
| Lowell Goodman | Tel: +1 (323) 646-3249 or [email protected] |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHKZGFVRGFGGZG
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.